Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Depreciation and Depletion: 2011-2025

Historic Depreciation and Depletion for Mesa Laboratories (MLAB) over the last 3 years, with Sep 2025 value amounting to $1.3 million.

  • Mesa Laboratories' Depreciation and Depletion fell 13.37% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 2.83%. This contributed to the annual value of $5.4 million for FY2025, which is 27.14% up from last year.
  • Latest data reveals that Mesa Laboratories reported Depreciation and Depletion of $1.3 million as of Q3 2025, which was down 6.34% from $1.4 million recorded in Q2 2025.
  • Mesa Laboratories' 5-year Depreciation and Depletion high stood at $1.5 million for Q3 2024, and its period low was $911,000 during Q3 2023.
  • Over the past 3 years, Mesa Laboratories' median Depreciation and Depletion value was $1.3 million (recorded in 2025), while the average stood at $1.2 million.
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first spiked by 66.63% in 2024, then decreased by 13.37% in 2025.
  • Quarterly analysis of 3 years shows Mesa Laboratories' Depreciation and Depletion stood at $1.1 million in 2023, then climbed by 2.98% to $1.1 million in 2024, then declined by 13.37% to $1.3 million in 2025.
  • Its Depreciation and Depletion was $1.3 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.4 million in Q1 2025.